Related references
Note: Only part of the references are listed.Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension
Maria G. Frid et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France
Eric Hachulla et al.
CHEST (2020)
Pulmonary arterial hypertension in systemic sclerosis-when criteria and pathobiology differ
Kristofer Andreasson et al.
RHEUMATOLOGY (2020)
New paradigm of B-cell biology regarding the elucidation of a new mechanism of tissue fibrosis in IgG4-related disease
Hiroshi Nakase et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Rituximab in systemic sclerosis A protocol for systematic review
Marina Maria Vieira de Figueiredo Caldas et al.
MEDICINE (2019)
Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension
Andrew J. Sweatt et al.
CIRCULATION RESEARCH (2019)
The immunopathogenesis of fibrosis in systemic sclerosis
M. Brown et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Clinical trial design and new therapies for pulmonary arterial hypertension
Olivier Sitbon et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Vivien M. Hsu et al.
JOURNAL OF RHEUMATOLOGY (2019)
Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review
Mathilde Thiebaut et al.
AUTOIMMUNITY REVIEWS (2018)
Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
Kathleen D. Kolstad et al.
CHEST (2018)
IgG4-related disease of pulmonary artery causing pulmonary hypertension
Hui Deng et al.
MEDICINE (2018)
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Geetabali Sircar et al.
RHEUMATOLOGY (2018)
Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations
Ewa Wielosz et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
Abdel Gaffar A. Mohammed et al.
ANNALS OF THORACIC MEDICINE (2017)
Pulmonary hypertension in systemic sclerosis: different phenotypes
David Launay et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Dynamics of the human antibody repertoire after B cell depletion in systemic sclerosis
Charles F. A. de Bourcy et al.
SCIENCE IMMUNOLOGY (2017)
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Kathleen Morrisroe et al.
ARTHRITIS RESEARCH & THERAPY (2017)
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets
Ayumi Yoshizaki
JOURNAL OF DERMATOLOGY (2016)
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study
Vanessa Smith et al.
JOURNAL OF RHEUMATOLOGY (2016)
Pulmonary arterial hypertension in a chronic lymphocytic leukemia patient in treatment with rituximab
Deodata Montrone et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
Monique Hinchcliff et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
Marlene Rabinovitch et al.
CIRCULATION RESEARCH (2014)
Bronchus-associated Lymphoid Tissue in Pulmonary Hypertension Produces Pathologic Autoantibodies
Kelley L. Colvin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Neal F. Chaisson et al.
CHEST (2013)
Right Ventricular Dysfunction in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Ryan J. Tedford et al.
CIRCULATION-HEART FAILURE (2013)
Rheumatoid Factors: Clinical Applications
Francesca Ingegnoli et al.
DISEASE MARKERS (2013)
A rheumatoid factor paradox: inhibition of rituximab effector function
Jonathan D. Jones et al.
ARTHRITIS RESEARCH & THERAPY (2013)
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
Maria J. Leandro
ARTHRITIS RESEARCH & THERAPY (2013)
The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension
Stephen C. Mathai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization
Shiro Mizuno et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Inflammation in Pulmonary Arterial Hypertension
Laura C. Price et al.
CHEST (2012)
Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL Identifying Systemic Sclerosis as a Unique Phenotype
Lorinda Chung et al.
CHEST (2010)
Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury
Sarah A. Pendergrass et al.
PLOS ONE (2010)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Increased IL-12 inhibits B cells' differentiation to germinal center cells and promotes differentiation to short-lived plasmablasts
Sun Jung Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
S. Hennigan et al.
LUPUS (2008)
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLOS ONE (2008)
Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study
Silvia Ulrich et al.
RESPIRATORY RESEARCH (2008)
Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab
D. McGonagle et al.
RHEUMATOLOGY (2008)
Drug Insight: the mechanism of action of rituximab in autoimmune disease - the immune complex decoy hypothesis
Ronald P. Taylor et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
M. C. Tamby et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2006)
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2006)
Autoimmunity and pulmonary hypertension: a perspective
MR Nicolls et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Isolated pulmonary hypertension in scleroderma
SR Cox et al.
INTERNAL MEDICINE JOURNAL (2005)
Altered blood B lymphocyte Homeostasis in systemic sclerosis - Expanded naive B cells and diminished but activated memory B cells
S Sato et al.
ARTHRITIS AND RHEUMATISM (2004)
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8
TM Bull et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement
V Steen et al.
ARTHRITIS AND RHEUMATISM (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Share Paper
